CA2936693C

CA2936693C - Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish

Chimeric antigen receptor using antigen recognition domains derived from cartilaginous fish Download PDF

Info

Publication number: CA2936693C
Authority: CA; Canada
Prior art keywords: cells; antigen receptor; cell; chain; seq
Prior art date: 2014-01-14
Legal status : Expired - Fee Related

Application number

CA2936693A

Other languages

English (en)

French (fr)

Other versions

CA2936693A1 (en

Inventor

Philippe Duchateau

Julien Valton

Current Assignee

Cellectis SA

Original Assignee

Cellectis SA

Priority date

2014-01-14

Filing date

2015-01-14

Publication date

2020-07-21

2015-01-14 Application filed by Cellectis SA filed Critical Cellectis SA

2015-07-23 Publication of CA2936693A1 publication Critical patent/CA2936693A1/en

2020-07-21 Application granted granted Critical

2020-07-21 Publication of CA2936693C publication Critical patent/CA2936693C/en

Status Expired - Fee Related legal-status Critical Current

2035-01-14 Anticipated expiration legal-status Critical

Links

108010019670 Chimeric Antigen Receptors Proteins 0.000 title claims abstract description 112
239000000427 antigen Substances 0.000 title claims abstract description 78
108091007433 antigens Proteins 0.000 title claims abstract description 78
102000036639 antigens Human genes 0.000 title claims abstract description 78
241000251468 Actinopterygii Species 0.000 title abstract description 6
210000004027 cell Anatomy 0.000 claims abstract description 202
108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 96
102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 87
229920001184 polypeptide Polymers 0.000 claims abstract description 84
210000002865 immune cell Anatomy 0.000 claims abstract description 37
239000003814 drug Substances 0.000 claims abstract description 15
229940079593 drug Drugs 0.000 claims abstract description 7
150000002500 ions Chemical class 0.000 claims abstract 3
206010028980 Neoplasm Diseases 0.000 claims description 48
238000011282 treatment Methods 0.000 claims description 32
235000001014 amino acid Nutrition 0.000 claims description 22
150000001413 amino acids Chemical class 0.000 claims description 20
230000004913 activation Effects 0.000 claims description 15
201000011510 cancer Diseases 0.000 claims description 15
238000002512 chemotherapy Methods 0.000 claims description 11
230000002463 transducing effect Effects 0.000 claims description 8
102000009109 Fc receptors Human genes 0.000 claims description 7
108010087819 Fc receptors Proteins 0.000 claims description 7
230000036210 malignancy Effects 0.000 claims description 7
125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 5
230000008685 targeting Effects 0.000 claims description 5
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
210000003719 b-lymphocyte Anatomy 0.000 claims description 4
230000000295 complement effect Effects 0.000 claims description 4
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 4
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 2
208000026278 immune system disease Diseases 0.000 claims 2
239000007788 liquid Substances 0.000 claims 2
108010065816 zeta chain antigen T cell receptor Proteins 0.000 claims 1
239000013598 vector Substances 0.000 abstract description 36
102000040430 polynucleotide Human genes 0.000 abstract description 19
108091033319 polynucleotide Proteins 0.000 abstract description 19
239000002157 polynucleotide Substances 0.000 abstract description 19
238000009169 immunotherapy Methods 0.000 abstract description 13
230000003211 malignant effect Effects 0.000 abstract description 5
210000001744 T-lymphocyte Anatomy 0.000 description 91
102000006306 Antigen Receptors Human genes 0.000 description 89
108010083359 Antigen Receptors Proteins 0.000 description 89
108090000623 proteins and genes Proteins 0.000 description 77
241000251152 Ginglymostoma cirratum Species 0.000 description 72
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 56
108091008874 T cell receptors Proteins 0.000 description 54
238000000034 method Methods 0.000 description 49
230000027455 binding Effects 0.000 description 38
239000003446 ligand Substances 0.000 description 32
102000004169 proteins and genes Human genes 0.000 description 27
235000018102 proteins Nutrition 0.000 description 26
150000007523 nucleic acids Chemical group 0.000 description 22
108020001756 ligand binding domains Proteins 0.000 description 21
102000005962 receptors Human genes 0.000 description 20
108020003175 receptors Proteins 0.000 description 20
108010042407 Endonucleases Proteins 0.000 description 18
230000011664 signaling Effects 0.000 description 18
125000003275 alpha amino acid group Chemical group 0.000 description 17
229940024606 amino acid Drugs 0.000 description 17
238000005520 cutting process Methods 0.000 description 17
239000003018 immunosuppressive agent Substances 0.000 description 17
208000037916 non-allergic rhinitis Diseases 0.000 description 17
229940125721 immunosuppressive agent Drugs 0.000 description 16
230000000670 limiting effect Effects 0.000 description 16
102100031780 Endonuclease Human genes 0.000 description 15
230000001506 immunosuppresive effect Effects 0.000 description 15
102000039446 nucleic acids Human genes 0.000 description 15
108020004707 nucleic acids Proteins 0.000 description 15
230000014509 gene expression Effects 0.000 description 14
230000036961 partial effect Effects 0.000 description 14
102100040678 Programmed cell death protein 1 Human genes 0.000 description 13
102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 description 13
208000009329 Graft vs Host Disease Diseases 0.000 description 11
241000700605 Viruses Species 0.000 description 11
208000024908 graft versus host disease Diseases 0.000 description 11
230000003248 secreting effect Effects 0.000 description 11
-1 CD78 Proteins 0.000 description 10
108010021064 CTLA-4 Antigen Proteins 0.000 description 10
102000003676 Glucocorticoid Receptors Human genes 0.000 description 10
108090000079 Glucocorticoid Receptors Proteins 0.000 description 10
230000006870 function Effects 0.000 description 10
230000000415 inactivating effect Effects 0.000 description 10
230000003612 virological effect Effects 0.000 description 10
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 9
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 9
102000008203 CTLA-4 Antigen Human genes 0.000 description 9
229940045513 CTLA4 antagonist Drugs 0.000 description 9
241000251730 Chondrichthyes Species 0.000 description 9
241000251784 Heterodontus francisci Species 0.000 description 9
239000003795 chemical substances by application Substances 0.000 description 9
230000035755 proliferation Effects 0.000 description 9
108010065524 CD52 Antigen Proteins 0.000 description 8
102000013135 CD52 Antigen Human genes 0.000 description 8
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 8
108091008036 Immune checkpoint proteins Proteins 0.000 description 8
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 8
108700018351 Major Histocompatibility Complex Proteins 0.000 description 8
108010076504 Protein Sorting Signals Proteins 0.000 description 8
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 8
229940045799 anthracyclines and related substance Drugs 0.000 description 8
210000004369 blood Anatomy 0.000 description 8
239000008280 blood Substances 0.000 description 8
238000004113 cell culture Methods 0.000 description 8
108020004999 messenger RNA Proteins 0.000 description 8
229960000485 methotrexate Drugs 0.000 description 8
125000003729 nucleotide group Chemical group 0.000 description 8
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 8
238000012546 transfer Methods 0.000 description 8
102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 7
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 7
102000004127 Cytokines Human genes 0.000 description 7
108090000695 Cytokines Proteins 0.000 description 7
102000053602 DNA Human genes 0.000 description 7
108020004414 DNA Proteins 0.000 description 7
101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 7
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 7
101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 7
239000012636 effector Substances 0.000 description 7
239000012634 fragment Substances 0.000 description 7
230000028993 immune response Effects 0.000 description 7
229960001156 mitoxantrone Drugs 0.000 description 7
KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 description 7
230000004048 modification Effects 0.000 description 7
238000012986 modification Methods 0.000 description 7
239000002773 nucleotide Substances 0.000 description 7
230000019491 signal transduction Effects 0.000 description 7
210000000130 stem cell Anatomy 0.000 description 7
102100024263 CD160 antigen Human genes 0.000 description 6
101150013553 CD40 gene Proteins 0.000 description 6
108020004705 Codon Proteins 0.000 description 6
230000007018 DNA scission Effects 0.000 description 6
102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 6
101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 6
101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 6
101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 6
102000037982 Immune checkpoint proteins Human genes 0.000 description 6
102000017578 LAG3 Human genes 0.000 description 6
102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 6
108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 6
241000415292 Orectolobus maculatus Species 0.000 description 6
101710089372 Programmed cell death protein 1 Proteins 0.000 description 6
102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 6
QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 6
102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 6
208000036142 Viral infection Diseases 0.000 description 6
230000005782 double-strand break Effects 0.000 description 6
230000000694 effects Effects 0.000 description 6
229920002477 rna polymer Polymers 0.000 description 6
238000006467 substitution reaction Methods 0.000 description 6
QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 6
102100038078 CD276 antigen Human genes 0.000 description 5
102100035793 CD83 antigen Human genes 0.000 description 5
201000009030 Carcinoma Diseases 0.000 description 5
101150046249 Havcr2 gene Proteins 0.000 description 5
101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 5
101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 5
101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 5
101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 5
101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 description 5
102100021339 Multidrug resistance-associated protein 1 Human genes 0.000 description 5
102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 5
108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 5
102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 description 5
229940122803 Vinca alkaloid Drugs 0.000 description 5
230000000139 costimulatory effect Effects 0.000 description 5
238000004520 electroporation Methods 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
238000001727 in vivo Methods 0.000 description 5
201000001441 melanoma Diseases 0.000 description 5
239000000203 mixture Substances 0.000 description 5
230000036457 multidrug resistance Effects 0.000 description 5
230000035772 mutation Effects 0.000 description 5
239000000126 substance Substances 0.000 description 5
235000000346 sugar Nutrition 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
102000003298 tumor necrosis factor receptor Human genes 0.000 description 5
208000031261 Acute myeloid leukaemia Diseases 0.000 description 4
102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 4
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
108010036949 Cyclosporine Proteins 0.000 description 4
101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 4
101000836954 Homo sapiens Sialic acid-binding Ig-like lectin 10 Proteins 0.000 description 4
101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 4
101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 4
102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 4
108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 4
108010002350 Interleukin-2 Proteins 0.000 description 4
102000000588 Interleukin-2 Human genes 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
108010038807 Oligopeptides Proteins 0.000 description 4
102000015636 Oligopeptides Human genes 0.000 description 4
102100027164 Sialic acid-binding Ig-like lectin 10 Human genes 0.000 description 4
241000251778 Squalus acanthias Species 0.000 description 4
230000006044 T cell activation Effects 0.000 description 4
108700042076 T-Cell Receptor alpha Genes Proteins 0.000 description 4
108700042077 T-Cell Receptor beta Genes Proteins 0.000 description 4
229940123237 Taxane Drugs 0.000 description 4
241001415779 Triakis scyllium Species 0.000 description 4
102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 4
102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 4
230000009471 action Effects 0.000 description 4
239000011324 bead Substances 0.000 description 4
230000008901 benefit Effects 0.000 description 4
229960001265 ciclosporin Drugs 0.000 description 4
229930182912 cyclosporin Natural products 0.000 description 4
230000001086 cytosolic effect Effects 0.000 description 4
230000004069 differentiation Effects 0.000 description 4
230000004927 fusion Effects 0.000 description 4
238000012239 gene modification Methods 0.000 description 4
230000005017 genetic modification Effects 0.000 description 4
235000013617 genetically modified food Nutrition 0.000 description 4
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
208000032839 leukemia Diseases 0.000 description 4
230000001404 mediated effect Effects 0.000 description 4
239000012528 membrane Substances 0.000 description 4
239000013612 plasmid Substances 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
230000009385 viral infection Effects 0.000 description 4
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 3
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 3
102100033350 ATP-dependent translocase ABCB1 Human genes 0.000 description 3
208000023275 Autoimmune disease Diseases 0.000 description 3
102100027207 CD27 antigen Human genes 0.000 description 3
102000001301 EGF receptor Human genes 0.000 description 3
108060006698 EGF receptor Proteins 0.000 description 3
102000004533 Endonucleases Human genes 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
208000032612 Glial tumor Diseases 0.000 description 3
206010018338 Glioma Diseases 0.000 description 3
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 3
101000969812 Homo sapiens Multidrug resistance-associated protein 1 Proteins 0.000 description 3
101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 description 3
108060003951 Immunoglobulin Proteins 0.000 description 3
102000004310 Ion Channels Human genes 0.000 description 3
206010058467 Lung neoplasm malignant Diseases 0.000 description 3
101100508818 Mus musculus Inpp5k gene Proteins 0.000 description 3
102100022683 NKG2-C type II integral membrane protein Human genes 0.000 description 3
101100366438 Rattus norvegicus Sphkap gene Proteins 0.000 description 3
206010039491 Sarcoma Diseases 0.000 description 3
108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 3
102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 3
108700019146 Transgenes Proteins 0.000 description 3
230000000735 allogeneic effect Effects 0.000 description 3
108010026331 alpha-Fetoproteins Proteins 0.000 description 3
102000013529 alpha-Fetoproteins Human genes 0.000 description 3
210000000612 antigen-presenting cell Anatomy 0.000 description 3
239000000969 carrier Substances 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
210000000170 cell membrane Anatomy 0.000 description 3
235000018417 cysteine Nutrition 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
210000004443 dendritic cell Anatomy 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
230000012010 growth Effects 0.000 description 3
239000003102 growth factor Substances 0.000 description 3
230000036737 immune function Effects 0.000 description 3
102000018358 immunoglobulin Human genes 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
230000002401 inhibitory effect Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
230000003834 intracellular effect Effects 0.000 description 3
230000004068 intracellular signaling Effects 0.000 description 3
201000005202 lung cancer Diseases 0.000 description 3
208000020816 lung neoplasm Diseases 0.000 description 3
239000002245 particle Substances 0.000 description 3
108010082091 pre-T cell receptor alpha Proteins 0.000 description 3
230000004044 response Effects 0.000 description 3
210000003705 ribosome Anatomy 0.000 description 3
230000007017 scission Effects 0.000 description 3
238000011426 transformation method Methods 0.000 description 3
230000001131 transforming effect Effects 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
241001430294 unidentified retrovirus Species 0.000 description 3
239000013603 viral vector Substances 0.000 description 3
IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
102000002627 4-1BB Ligand Human genes 0.000 description 2
108010082808 4-1BB Ligand Proteins 0.000 description 2
206010000830 Acute leukaemia Diseases 0.000 description 2
102100038080 B-cell receptor CD22 Human genes 0.000 description 2
102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
108010074708 B7-H1 Antigen Proteins 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
102100025221 CD70 antigen Human genes 0.000 description 2
108091033409 CRISPR Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 2
102000001493 Cyclophilins Human genes 0.000 description 2
108010068682 Cyclophilins Proteins 0.000 description 2
229930105110 Cyclosporin A Natural products 0.000 description 2
UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 2
230000004568 DNA-binding Effects 0.000 description 2
102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 2
108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
241000251150 Ginglymostoma Species 0.000 description 2
102100028967 HLA class I histocompatibility antigen, alpha chain G Human genes 0.000 description 2
108010024164 HLA-G Antigens Proteins 0.000 description 2
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
101001017818 Homo sapiens ATP-dependent translocase ABCB1 Proteins 0.000 description 2
101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 2
101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
101000823298 Homo sapiens Broad substrate specificity ATP-binding cassette transporter ABCG2 Proteins 0.000 description 2
101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 2
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
101000984189 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 2 Proteins 0.000 description 2
101000984186 Homo sapiens Leukocyte immunoglobulin-like receptor subfamily B member 4 Proteins 0.000 description 2
101000874179 Homo sapiens Syndecan-1 Proteins 0.000 description 2
101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 description 2
101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 2
101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 2
102000004877 Insulin Human genes 0.000 description 2
108090001061 Insulin Proteins 0.000 description 2
102100034343 Integrase Human genes 0.000 description 2
102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108020003285 Isocitrate lyase Proteins 0.000 description 2
102100034872 Kallikrein-4 Human genes 0.000 description 2
239000005517 L01XE01 - Imatinib Substances 0.000 description 2
102100025583 Leukocyte immunoglobulin-like receptor subfamily B member 2 Human genes 0.000 description 2
102100025578 Leukocyte immunoglobulin-like receptor subfamily B member 4 Human genes 0.000 description 2
206010025323 Lymphomas Diseases 0.000 description 2
102000018170 Lymphotoxin beta Receptor Human genes 0.000 description 2
108010091221 Lymphotoxin beta Receptor Proteins 0.000 description 2
102100030301 MHC class I polypeptide-related sequence A Human genes 0.000 description 2
108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 2
108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 2
101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 2
206010029260 Neuroblastoma Diseases 0.000 description 2
208000030852 Parasitic disease Diseases 0.000 description 2
108010047620 Phytohemagglutinins Proteins 0.000 description 2
241000709664 Picornaviridae Species 0.000 description 2
108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 2
102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 2
102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
102100035721 Syndecan-1 Human genes 0.000 description 2
230000005867 T cell response Effects 0.000 description 2
108010092262 T-Cell Antigen Receptors Proteins 0.000 description 2
108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 2
102100026144 Transferrin receptor protein 1 Human genes 0.000 description 2
102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 2
102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 2
238000010317 ablation therapy Methods 0.000 description 2
RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
239000000654 additive Substances 0.000 description 2
WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 description 2
239000000556 agonist Substances 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
238000013459 approach Methods 0.000 description 2
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 2
230000003190 augmentative effect Effects 0.000 description 2
WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
229950008548 bisantrene Drugs 0.000 description 2
230000037396 body weight Effects 0.000 description 2
210000001185 bone marrow Anatomy 0.000 description 2
239000002458 cell surface marker Substances 0.000 description 2
239000012829 chemotherapy agent Substances 0.000 description 2
230000002759 chromosomal effect Effects 0.000 description 2
229960004316 cisplatin Drugs 0.000 description 2
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
239000003246 corticosteroid Substances 0.000 description 2
239000013078 crystal Substances 0.000 description 2
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
210000005220 cytoplasmic tail Anatomy 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
241001493065 dsRNA viruses Species 0.000 description 2
210000004700 fetal blood Anatomy 0.000 description 2
238000001476 gene delivery Methods 0.000 description 2
238000001415 gene therapy Methods 0.000 description 2
230000002068 genetic effect Effects 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 2
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
210000002443 helper t lymphocyte Anatomy 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
210000005260 human cell Anatomy 0.000 description 2
KTUFNOKKBVMGRW-UHFFFAOYSA-N imatinib Chemical compound C1CN(C)CCN1CC1=CC=C(C(=O)NC=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)C=C1 KTUFNOKKBVMGRW-UHFFFAOYSA-N 0.000 description 2
229960002411 imatinib Drugs 0.000 description 2
230000005931 immune cell recruitment Effects 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000002650 immunosuppressive therapy Methods 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
230000001939 inductive effect Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
229940125396 insulin Drugs 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
108010024383 kallikrein 4 Proteins 0.000 description 2
108010025001 leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000003550 marker Substances 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000010445 mica Substances 0.000 description 2
229910052618 mica group Inorganic materials 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
108010066052 multidrug resistance-associated protein 1 Proteins 0.000 description 2
NJSMWLQOCQIOPE-OCHFTUDZSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine Chemical compound N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 NJSMWLQOCQIOPE-OCHFTUDZSA-N 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
230000037361 pathway Effects 0.000 description 2
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 2
230000001885 phytohemagglutinin Effects 0.000 description 2
238000003752 polymerase chain reaction Methods 0.000 description 2
230000000069 prophylactic effect Effects 0.000 description 2
108020001580 protein domains Proteins 0.000 description 2
150000003212 purines Chemical class 0.000 description 2
150000003230 pyrimidines Chemical class 0.000 description 2
238000001959 radiotherapy Methods 0.000 description 2
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
238000010839 reverse transcription Methods 0.000 description 2
229960002930 sirolimus Drugs 0.000 description 2
DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
241000894007 species Species 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
239000000758 substrate Substances 0.000 description 2
229960001967 tacrolimus Drugs 0.000 description 2
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
238000013519 translation Methods 0.000 description 2
230000032258 transport Effects 0.000 description 2
241000712461 unidentified influenza virus Species 0.000 description 2
230000035899 viability Effects 0.000 description 2
FFILOTSTFMXQJC-QCFYAKGBSA-N (2r,4r,5s,6s)-2-[3-[(2s,3s,4r,6s)-6-[(2s,3r,4r,5s,6r)-5-[(2s,3r,4r,5r,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(e)-3-hydroxy-2-(octadecanoylamino)octadec-4-enoxy]oxan-3-yl]oxy-3-hy Chemical compound O[C@@H]1[C@@H](O)[C@H](OCC(NC(=O)CCCCCCCCCCCCCCCCC)C(O)\C=C\CCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO[C@]2(O[C@@H]([C@@H](N)[C@H](O)C2)C(O)C(O)CO)C(O)=O)C(O)=O)[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](CO)O1 FFILOTSTFMXQJC-QCFYAKGBSA-N 0.000 description 1
NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 1
HIYAVKIYRIFSCZ-CYEMHPAKSA-N 5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid Chemical compound O=C([C@@H](C)[C@H]1O[C@@]2([C@@H](C[C@H]1C)C)O[C@@H]([C@@H](CC2)C)CC=1OC2=CC=C(C(=C2N=1)C(O)=O)NC)C1=CC=CN1 HIYAVKIYRIFSCZ-CYEMHPAKSA-N 0.000 description 1
108010013238 70-kDa Ribosomal Protein S6 Kinases Proteins 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
102100033618 ATP-binding cassette sub-family A member 2 Human genes 0.000 description 1
102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 description 1
102100028162 ATP-binding cassette sub-family C member 3 Human genes 0.000 description 1
102100028187 ATP-binding cassette sub-family C member 6 Human genes 0.000 description 1
206010069754 Acquired gene mutation Diseases 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
101710145634 Antigen 1 Proteins 0.000 description 1
241000710189 Aphthovirus Species 0.000 description 1
101100279855 Arabidopsis thaliana EPFL5 gene Proteins 0.000 description 1
108010031480 Artificial Receptors Proteins 0.000 description 1
206010003445 Ascites Diseases 0.000 description 1
108010008014 B-Cell Maturation Antigen Proteins 0.000 description 1
102000006942 B-Cell Maturation Antigen Human genes 0.000 description 1
102100028282 Bile salt export pump Human genes 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
102100026094 C-type lectin domain family 12 member A Human genes 0.000 description 1
210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
101150031358 COLEC10 gene Proteins 0.000 description 1
102000004631 Calcineurin Human genes 0.000 description 1
108010042955 Calcineurin Proteins 0.000 description 1
229940122739 Calcineurin inhibitor Drugs 0.000 description 1
101710192106 Calcineurin-binding protein cabin-1 Proteins 0.000 description 1
102100024123 Calcineurin-binding protein cabin-1 Human genes 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
102100025570 Cancer/testis antigen 1 Human genes 0.000 description 1
108010051152 Carboxylesterase Proteins 0.000 description 1
102000013392 Carboxylesterase Human genes 0.000 description 1
102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 description 1
108010078791 Carrier Proteins Proteins 0.000 description 1
108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
102100025064 Cellular tumor antigen p53 Human genes 0.000 description 1
VWFCHDSQECPREK-LURJTMIESA-N Cidofovir Chemical compound NC=1C=CN(C[C@@H](CO)OCP(O)(O)=O)C(=O)N=1 VWFCHDSQECPREK-LURJTMIESA-N 0.000 description 1
108020004638 Circular DNA Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108010047041 Complementarity Determining Regions Proteins 0.000 description 1
241000711573 Coronaviridae Species 0.000 description 1
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
102000013816 Cytotoxic T-lymphocyte antigen 4 Human genes 0.000 description 1
102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
241000450599 DNA viruses Species 0.000 description 1
108010092160 Dactinomycin Proteins 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
101150029707 ERBB2 gene Proteins 0.000 description 1
102100037241 Endoglin Human genes 0.000 description 1
108010036395 Endoglin Proteins 0.000 description 1
102100023721 Ephrin-B2 Human genes 0.000 description 1
108010044090 Ephrin-B2 Proteins 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
208000000666 Fowlpox Diseases 0.000 description 1
YPINZEGNLULHHT-UHFFFAOYSA-N Fujimycin Natural products COC1CC(CCC1O)C=C(/C)C2OC(=O)C3CCCCCN3C(=O)C(=O)C4(O)OC(C(CC4C)OC)C(OC)C(C)CC(=CC(CC=C)C(=O)CC(O)C2C)C YPINZEGNLULHHT-UHFFFAOYSA-N 0.000 description 1
241001416183 Ginglymostomatidae Species 0.000 description 1
102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
102100028113 Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Human genes 0.000 description 1
241000941423 Grom virus Species 0.000 description 1
108010009202 Growth Factor Receptors Proteins 0.000 description 1
102000009465 Growth Factor Receptors Human genes 0.000 description 1
108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 description 1
102100038006 High affinity immunoglobulin epsilon receptor subunit alpha Human genes 0.000 description 1
108050001540 High affinity immunoglobulin epsilon receptor subunit beta Proteins 0.000 description 1
102100022132 High affinity immunoglobulin epsilon receptor subunit gamma Human genes 0.000 description 1
108091010847 High affinity immunoglobulin epsilon receptor subunit gamma Proteins 0.000 description 1
102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000801645 Homo sapiens ATP-binding cassette sub-family A member 2 Proteins 0.000 description 1
101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 description 1
101000986633 Homo sapiens ATP-binding cassette sub-family C member 3 Proteins 0.000 description 1
101000986621 Homo sapiens ATP-binding cassette sub-family C member 6 Proteins 0.000 description 1
101100496086 Homo sapiens CLEC12A gene Proteins 0.000 description 1
101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 description 1
101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 description 1
101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 description 1
101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
101000916625 Homo sapiens Granulocyte-macrophage colony-stimulating factor receptor subunit alpha Proteins 0.000 description 1
101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 description 1
101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 description 1
101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 description 1
101001023379 Homo sapiens Lysosome-associated membrane glycoprotein 1 Proteins 0.000 description 1
101001014223 Homo sapiens MAPK/MAK/MRK overlapping kinase Proteins 0.000 description 1
101001008874 Homo sapiens Mast/stem cell growth factor receptor Kit Proteins 0.000 description 1
101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 1
101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 description 1
101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
101000801640 Homo sapiens Phospholipid-transporting ATPase ABCA3 Proteins 0.000 description 1
101000610551 Homo sapiens Prominin-1 Proteins 0.000 description 1
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 1
101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 1
101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 description 1
101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 description 1
101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 1
101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 1
241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 description 1
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108090001117 Insulin-Like Growth Factor II Proteins 0.000 description 1
102000048143 Insulin-Like Growth Factor II Human genes 0.000 description 1
102100037852 Insulin-like growth factor I Human genes 0.000 description 1
108010061833 Integrases Proteins 0.000 description 1
102000014150 Interferons Human genes 0.000 description 1
108010050904 Interferons Proteins 0.000 description 1
108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
108010002386 Interleukin-3 Proteins 0.000 description 1
102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
108090001090 Lectins Proteins 0.000 description 1
102000004856 Lectins Human genes 0.000 description 1
241000713666 Lentivirus Species 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
108010028275 Leukocyte Elastase Proteins 0.000 description 1
102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 description 1
102100035133 Lysosome-associated membrane glycoprotein 1 Human genes 0.000 description 1
102100031520 MAPK/MAK/MRK overlapping kinase Human genes 0.000 description 1
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 1
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
108010047230 Member 1 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
108010093662 Member 11 Subfamily B ATP Binding Cassette Transporter Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
108090000015 Mesothelin Proteins 0.000 description 1
102000003735 Mesothelin Human genes 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102000016943 Muramidase Human genes 0.000 description 1
108010014251 Muramidase Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100519207 Mus musculus Pdcd1 gene Proteins 0.000 description 1
101100268066 Mus musculus Zap70 gene Proteins 0.000 description 1
102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
102100022680 NKG2-D type II integral membrane protein Human genes 0.000 description 1
108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
102100033174 Neutrophil elastase Human genes 0.000 description 1
241000714209 Norwalk virus Species 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
206010030155 Oesophageal carcinoma Diseases 0.000 description 1
108091034117 Oligonucleotide Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
241000415294 Orectolobidae Species 0.000 description 1
241000415293 Orectolobus Species 0.000 description 1
241000702244 Orthoreovirus Species 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 1
102100033623 Phospholipid-transporting ATPase ABCA3 Human genes 0.000 description 1
208000002151 Pleural effusion Diseases 0.000 description 1
102100040120 Prominin-1 Human genes 0.000 description 1
102000003923 Protein Kinase C Human genes 0.000 description 1
108090000315 Protein Kinase C Proteins 0.000 description 1
108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 1
102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 1
241000125945 Protoparvovirus Species 0.000 description 1
201000004681 Psoriasis Diseases 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
241000711798 Rabies lyssavirus Species 0.000 description 1
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 1
206010070308 Refractory cancer Diseases 0.000 description 1
241000712907 Retroviridae Species 0.000 description 1
241000283984 Rodentia Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
102100038081 Signal transducer CD24 Human genes 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
102100037253 Solute carrier family 45 member 3 Human genes 0.000 description 1
241000713675 Spumavirus Species 0.000 description 1
241000782099 Squaliformes Species 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
230000006052 T cell proliferation Effects 0.000 description 1
102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 description 1
102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 description 1
102100035268 T-cell surface protein tactile Human genes 0.000 description 1
102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 1
108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 1
108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 1
108010017842 Telomerase Proteins 0.000 description 1
102000007000 Tenascin Human genes 0.000 description 1
108010008125 Tenascin Proteins 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
101800000385 Transmembrane protein Proteins 0.000 description 1
108010080432 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Proteins 0.000 description 1
102000000160 Tumor Necrosis Factor Receptor-Associated Peptides and Proteins Human genes 0.000 description 1
102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 1
206010046865 Vaccinia virus infection Diseases 0.000 description 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
241000711975 Vesicular stomatitis virus Species 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
108020000999 Viral RNA Proteins 0.000 description 1
108010017070 Zinc Finger Nucleases Proteins 0.000 description 1
INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
229960004308 acetylcysteine Drugs 0.000 description 1
239000002253 acid Substances 0.000 description 1
RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
210000004504 adult stem cell Anatomy 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
BIIVYFLTOXDAOV-YVEFUNNKSA-N alvocidib Chemical compound O[C@@H]1CN(C)CC[C@@H]1C1=C(O)C=C(O)C2=C1OC(C=1C(=CC=CC=1)Cl)=CC2=O BIIVYFLTOXDAOV-YVEFUNNKSA-N 0.000 description 1
229950010817 alvocidib Drugs 0.000 description 1
150000001412 amines Chemical class 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000340 anti-metabolite Effects 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000009175 antibody therapy Methods 0.000 description 1
229940100197 antimetabolite Drugs 0.000 description 1
239000002256 antimetabolite Substances 0.000 description 1
230000006907 apoptotic process Effects 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
238000003556 assay Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
208000004668 avian leukosis Diseases 0.000 description 1
229960002170 azathioprine Drugs 0.000 description 1
LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
239000002551 biofuel Substances 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
229940126587 biotherapeutics Drugs 0.000 description 1
201000000053 blastoma Diseases 0.000 description 1
238000010504 bond cleavage reaction Methods 0.000 description 1
238000010322 bone marrow transplantation Methods 0.000 description 1
229960005520 bryostatin Drugs 0.000 description 1
MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 description 1
MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
239000003710 calcium ionophore Substances 0.000 description 1
HIYAVKIYRIFSCZ-UHFFFAOYSA-N calcium ionophore A23187 Natural products N=1C2=C(C(O)=O)C(NC)=CC=C2OC=1CC(C(CC1)C)OC1(C(CC1C)C)OC1C(C)C(=O)C1=CC=CN1 HIYAVKIYRIFSCZ-UHFFFAOYSA-N 0.000 description 1
125000002837 carbocyclic group Chemical group 0.000 description 1
101150090505 cas10 gene Proteins 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000002659 cell therapy Methods 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000036755 cellular response Effects 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
208000011654 childhood malignant neoplasm Diseases 0.000 description 1
208000012191 childhood neoplasm Diseases 0.000 description 1
108700010039 chimeric receptor Proteins 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
229960000724 cidofovir Drugs 0.000 description 1
229960001338 colchicine Drugs 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
229960004397 cyclophosphamide Drugs 0.000 description 1
229960000684 cytarabine Drugs 0.000 description 1
102000003675 cytokine receptors Human genes 0.000 description 1
108010057085 cytokine receptors Proteins 0.000 description 1
230000001461 cytolytic effect Effects 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000003013 cytotoxicity Effects 0.000 description 1
231100000135 cytotoxicity Toxicity 0.000 description 1
229960000640 dactinomycin Drugs 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
239000000412 dendrimer Substances 0.000 description 1
229920000736 dendritic polymer Polymers 0.000 description 1
238000011161 development Methods 0.000 description 1
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
229960003957 dexamethasone Drugs 0.000 description 1
OZRNSSUDZOLUSN-LBPRGKRZSA-N dihydrofolic acid Chemical compound N=1C=2C(=O)NC(N)=NC=2NCC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OZRNSSUDZOLUSN-LBPRGKRZSA-N 0.000 description 1
230000003828 downregulation Effects 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
239000002961 echo contrast media Substances 0.000 description 1
201000008184 embryoma Diseases 0.000 description 1
210000001671 embryonic stem cell Anatomy 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000004049 epigenetic modification Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
FRPJXPJMRWBBIH-RBRWEJTLSA-N estramustine Chemical compound ClCCN(CCCl)C(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 FRPJXPJMRWBBIH-RBRWEJTLSA-N 0.000 description 1
229960001842 estramustine Drugs 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
238000002710 external beam radiation therapy Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
229960000390 fludarabine Drugs 0.000 description 1
GIUYCYHIANZCFB-FJFJXFQQSA-N fludarabine phosphate Chemical compound C1=NC=2C(N)=NC(F)=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O GIUYCYHIANZCFB-FJFJXFQQSA-N 0.000 description 1
230000037406 food intake Effects 0.000 description 1
230000004077 genetic alteration Effects 0.000 description 1
231100000118 genetic alteration Toxicity 0.000 description 1
230000030414 genetic transfer Effects 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
150000002339 glycosphingolipids Chemical class 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
230000036541 health Effects 0.000 description 1
201000005787 hematologic cancer Diseases 0.000 description 1
208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 1
210000003958 hematopoietic stem cell Anatomy 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
210000003630 histaminocyte Anatomy 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
229940084986 human chorionic gonadotropin Drugs 0.000 description 1
125000001165 hydrophobic group Chemical group 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
210000001822 immobilized cell Anatomy 0.000 description 1
230000005965 immune activity Effects 0.000 description 1
230000006450 immune cell response Effects 0.000 description 1
229940126546 immune checkpoint molecule Drugs 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
229960003444 immunosuppressant agent Drugs 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
235000013902 inosinic acid Nutrition 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000005732 intercellular adhesion Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
230000017307 interleukin-4 production Effects 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
238000005304 joining Methods 0.000 description 1
239000002523 lectin Substances 0.000 description 1
239000002502 liposome Substances 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
239000003287 lymphocyte surface marker Substances 0.000 description 1
210000003563 lymphoid tissue Anatomy 0.000 description 1
229960000274 lysozyme Drugs 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000004325 lysozyme Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 1
238000012737 microarray-based gene expression Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
230000001617 migratory effect Effects 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
238000012243 multiplex automated genomic engineering Methods 0.000 description 1
230000036438 mutation frequency Effects 0.000 description 1
231100000376 mutation frequency increase Toxicity 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
229940014456 mycophenolate Drugs 0.000 description 1
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 1
239000002105 nanoparticle Substances 0.000 description 1
201000011216 nasopharynx carcinoma Diseases 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
239000002777 nucleoside Substances 0.000 description 1
150000003833 nucleoside derivatives Chemical class 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000008520 organization Effects 0.000 description 1
230000002611 ovarian Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
230000035699 permeability Effects 0.000 description 1
230000008823 permeabilization Effects 0.000 description 1
238000011458 pharmacological treatment Methods 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
238000001126 phototherapy Methods 0.000 description 1
108010058237 plasma protein fraction Proteins 0.000 description 1
229940002993 plasmanate Drugs 0.000 description 1
229920001481 poly(stearyl methacrylate) Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
108010079891 prostein Proteins 0.000 description 1
239000002213 purine nucleotide Substances 0.000 description 1
239000002719 pyrimidine nucleotide Substances 0.000 description 1
230000005855 radiation Effects 0.000 description 1
208000016691 refractory malignant neoplasm Diseases 0.000 description 1
210000003289 regulatory T cell Anatomy 0.000 description 1
238000011160 research Methods 0.000 description 1
229960004641 rituximab Drugs 0.000 description 1
229960003452 romidepsin Drugs 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
108010085082 sigma receptors Proteins 0.000 description 1
230000009131 signaling function Effects 0.000 description 1
229940054269 sodium pyruvate Drugs 0.000 description 1
239000000243 solution Substances 0.000 description 1
230000037439 somatic mutation Effects 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000011272 standard treatment Methods 0.000 description 1
238000011476 stem cell transplantation Methods 0.000 description 1
150000003431 steroids Chemical class 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
101150047061 tag-72 gene Proteins 0.000 description 1
229940113082 thymine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
210000003014 totipotent stem cell Anatomy 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
230000005945 translocation Effects 0.000 description 1
102000035160 transmembrane proteins Human genes 0.000 description 1
108091005703 transmembrane proteins Proteins 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000007723 transport mechanism Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
238000005829 trimerization reaction Methods 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1
231100000588 tumorigenic Toxicity 0.000 description 1
230000000381 tumorigenic effect Effects 0.000 description 1
230000007306 turnover Effects 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
230000003827 upregulation Effects 0.000 description 1
208000007089 vaccinia Diseases 0.000 description 1
239000004474 valine Substances 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
229960002555 zidovudine Drugs 0.000 description 1